Hepatoblastoma: Is it really un-resectable?

Aim: This study aims to evaluate the results of the patients with hepatoblastoma who underwent resection or liver transplantation. Material and Methods: The patients referred to our clinic for liver transplantation due to un-resectable hepatoblastoma were included in the study. They were evaluated according to demographic findings, alpha feto-protein level, the surgery type, and clinical results. Results: Between 2006 and 2020, 32 patients with hepatoblastoma were investigated among all liver transplant patients. All patients have been referred to us because of unresectable hepatoblastoma. Twenty-five patients underwent liver transplantation, and the other seven underwent hepatic resection without transplantation. The donor preparation has been done for all patients, including the resection group. The overall survival rate was 76% for transplant patients and 71.4% for resection patients. Conclusions: LT is an important surgical solution in patients with unresectable hepatoblastoma. In the state of requiring extended resection, preparing a donor simultaneously provides surgical options during the surgery.

PDF

___

1. Tianyou Y, Richard S. Whitlock and Sanjeev A. Vasudevan. Surgical management of hepatoblastoma and recent advances. Cancers 2019, 11, 1944.
2. Darbari A. Sabin, K.M.; Shapiro, C.N.; Schwarz, K.B. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003, 38, 560–566.
3. Stiller CA, Pritchard J and Steliarova-Foucher E: Liver cancer in European children: Incidence and survival, 1978-1997. Report from the automated childhood cancer information system project. Eur J Cancer 42: 2115-2123, 2006.
4. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN and Tefft M: Combination chemotherapy (vincristine, adriamycin, cyclophosphamide and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50: 821-826, 1982.
5. Tiao GM, Bobey N, Allen S, Nieves N, Alonso M, Bucuvalas J, Wells R and Ryckman F: The current management of hepatoblastoma: A combination of chemotherapy, conventional resection and liver transplantation. J Pediatr 146: 204-211, 2005.
6. Pritchard J and Stringer M: Outcome and complications after resection of hepatoblastoma. J Pediatr Surg 39: 1744-1745, 2004.
7. Zhang Y, Zhang WL, Huang DS, Hong L, Wang YZ, Zhu X, Hu HM, Zhang PW, Yi Y and Han T: Clinical effectiveness of multimodality treatment on advanced pediatric hepatoblastoma. Eur Rev Med Pharmacol Sci 18: 1018-1026, 2014.
8. Malogolowkin, M.H.; Katzenstein, H.M.; Meyers, R.L.; Krailo, M.D.; Rowland, J.M.; Haas, J.; Finegold, M.J. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the Children’s Oncology Group. J. Clin. Oncol. 2011, 29, 3301–3306.
9. Starzl TE, Groth CG, Brettschneider L, et al. Extended survival in three cases of orthotopic homotransplantation of the human liver. Surgery. 1968;63(4):549-563.
10. Sergi CM, editor. Liver Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 Apr 6. PMID: 33905186.
11. Riikonen P, Tuominen L, Seppa A, Perkkio M. Simultaneous hepatoblastoma in identical male twins. Cancer. 1990;66(11):2429-2431.
12. Uchida H, Sakamoto S, Kasahara M, Ueno Y, Mochida S, Haga H, Okajima H, Eguchi S, Takada Y, Umeshita K, Kokudo N, Egawa H, Uemoto S, Ohdan H; Japanese Liver Transplantation Society. An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan. Transpl Int. 2021 Aug;34(8):1408-1421. doi: 10.1111/tri.13924. Epub 2021 Jun 22. PMID: 34021931.
13. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg. 2002;37(2):240-245.
14. Cillo U, Ciarleglio FA, Bassanello M, et al. Liver transplantation for the management of hepatoblastoma. Transplant Proc. 2003;35(8): 2983-2985.
15. Kulkarni S, Brauer DG, Turmelle Y, Stoll J, Nadler M, Chapman WC, Doyle MB, Khan AS. Surgical therapy for pediatric hepatoblastoma in the USA over the last decade: Analysis of the National Cancer Database. J Gastrointest Cancer. 2021 Jun;52(2):547-556. doi: 10.1007/s12029-020-00421-z. PMID: 32458263.